138 related articles for article (PubMed ID: 37997470)
1. A Comprehensive Study of Heterogeneous Mismatch Repair Expression in Solid Tumors Reveals Different Immunohistochemical Patterns and Distinct Genetic Mechanisms.
Wang J; Zhang Z; Cai Y; Lu J; Zhang H; Pang J; Wu H; Liang Z
Am J Surg Pathol; 2024 Apr; 48(4):417-425. PubMed ID: 37997470
[TBL] [Abstract][Full Text] [Related]
2. Rare germline mutation and MSH2-&MSH6 + expression in a double primary carcinoma of colorectal carcinoma and endometrial carcinoma: a case report.
Zhang T; Huang X; Liu W; Ling X; Su Z; Huang M; Che S
Diagn Pathol; 2024 Jan; 19(1):25. PubMed ID: 38297350
[TBL] [Abstract][Full Text] [Related]
3. Relationship between MLH1, PMS2, MSH2 and MSH6 gene-specific alterations and tumor mutational burden in 1057 microsatellite instability-high solid tumors.
Salem ME; Bodor JN; Puccini A; Xiu J; Goldberg RM; Grothey A; Korn WM; Shields AF; Worrilow WM; Kim ES; Lenz HJ; Marshall JL; Hall MJ
Int J Cancer; 2020 Nov; 147(10):2948-2956. PubMed ID: 32449172
[TBL] [Abstract][Full Text] [Related]
4. [Comprehensive assessment of mismatch repair and microsatellite instability status in molecular classification of endometrial carcinoma].
Liu Y; Wang YX; Sun XJ; Ting X; Wu R; Liu XD; Liu CR
Zhonghua Fu Chan Ke Za Zhi; 2023 Oct; 58(10):755-765. PubMed ID: 37849256
[No Abstract] [Full Text] [Related]
5. Epigenetic MLH1 silencing concurs with mismatch repair deficiency in sporadic, naturally occurring colorectal cancer in rhesus macaques.
Deycmar S; Johnson BJ; Ray K; Schaaf GW; Ryan DP; Cullin C; Dozier BL; Ferguson B; Bimber BN; Olson JD; Caudell DL; Whitlow CT; Solingapuram Sai KK; Romero EC; Villinger FJ; Burgos AG; Ainsworth HC; Miller LD; Hawkins GA; Chou JW; Gomes B; Hettich M; Ceppi M; Charo J; Cline JM
J Transl Med; 2024 Mar; 22(1):292. PubMed ID: 38504345
[TBL] [Abstract][Full Text] [Related]
6. Molecular Basis of Mismatch Repair Protein Deficiency in Tumors from Lynch Suspected Cases with Negative Germline Test Results.
Olkinuora A; Gylling A; Almusa H; Eldfors S; Lepistö A; Mecklin JP; Nieminen TT; Peltomäki P
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32660107
[TBL] [Abstract][Full Text] [Related]
7. [Correlation between mismatch-repair protein expression and clinicopathologic features in 658 colorectal cancers].
Hu XR; Xu C; Kang Y; Wang T; Zhang Y; Yang XH
Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):827-833. PubMed ID: 30423605
[No Abstract] [Full Text] [Related]
8. Characteristics of Mismatch Repair-Deficient Colon Cancer in Relation to Mismatch Repair Protein Loss, Hypermethylation Silencing, and Constitutional and Biallelic Somatic Mismatch Repair Gene Pathogenic Variants.
Keshinro A; Ganesh K; Vanderbilt C; Firat C; Kim JK; Chen CT; Yaeger R; Segal NH; Gonen M; Shia J; Stadler ZK; Weiser MR
Dis Colon Rectum; 2023 Apr; 66(4):549-558. PubMed ID: 35724254
[TBL] [Abstract][Full Text] [Related]
9. Analysis of 108 patients with endometrial carcinoma using the PROMISE classification and additional genetic analyses for MMR-D.
Timmerman S; Van Rompuy AS; Van Gorp T; Vanden Bempt I; Brems H; Van Nieuwenhuysen E; Han SN; Neven P; Victoor J; Laenen A; Vergote I
Gynecol Oncol; 2020 Apr; 157(1):245-251. PubMed ID: 31980219
[TBL] [Abstract][Full Text] [Related]
10. Concurrent loss of MLH1, PMS2 and MSH6 immunoexpression in digestive system cancers indicating a widespread dysregulation in DNA repair processes.
Reitsam NG; Märkl B; Dintner S; Waidhauser J; Vlasenko D; Grosser B
Front Oncol; 2022; 12():1019798. PubMed ID: 36387226
[TBL] [Abstract][Full Text] [Related]
11. Endometrial Carcinomas With Subclonal Loss of Mismatch Repair Proteins: A Clinicopathologic and Genomic Study.
Mendoza RP; Wang P; Schulte JJ; Tjota MY; Jani I; Martinez AC; Haridas R; Wanjari P; Steinhardt G; Brown N; Betz BL; Chapel DB; Kertowidjojo E; Yamada SD; Bennett JA
Am J Surg Pathol; 2023 May; 47(5):589-598. PubMed ID: 36866757
[TBL] [Abstract][Full Text] [Related]
12. Unique Patterns of Heterogeneous Mismatch Repair Protein Expression in Colorectal Cancer Unveil Different Degrees of Tumor Mutational Burden and Distinct Tumor Microenvironment Features.
Berrino E; Aquilano MC; Valtorta E; Amodio V; Germano G; Gusmini M; Gizzi K; Fenocchio E; Sapino A; Marsoni S; Sartore-Bianchi A; Bardelli A; Siena S; Bonoldi E; Marchiò C
Mod Pathol; 2023 Feb; 36(2):100012. PubMed ID: 36853785
[TBL] [Abstract][Full Text] [Related]
13. Assessing Mismatch Repair Expression by Immunohistochemistry in Colorectal Adenocarcinoma -Insight from a Tertiary Care Centre.
Lakhe R; Doshi R; Doshi P; Patil A; Nimbargi R
Gulf J Oncolog; 2024 May; 1(45):35-41. PubMed ID: 38774931
[TBL] [Abstract][Full Text] [Related]
14. MSH6 immunohistochemical heterogeneity in colorectal cancer: comparative sequencing from different tumor areas.
Chen W; Pearlman R; Hampel H; Pritchard CC; Markow M; Arnold C; Knight D; Frankel WL
Hum Pathol; 2020 Feb; 96():104-111. PubMed ID: 31783044
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical null-phenotype for mismatch repair proteins in colonic carcinoma associated with concurrent MLH1 hypermethylation and MSH2 somatic mutations.
Wang T; Stadler ZK; Zhang L; Weiser MR; Basturk O; Hechtman JF; Vakiani E; Saltz LB; Klimstra DS; Shia J
Fam Cancer; 2018 Apr; 17(2):225-228. PubMed ID: 28819720
[TBL] [Abstract][Full Text] [Related]
16. Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing.
Buchanan DD; Tan YY; Walsh MD; Clendenning M; Metcalf AM; Ferguson K; Arnold ST; Thompson BA; Lose FA; Parsons MT; Walters RJ; Pearson SA; Cummings M; Oehler MK; Blomfield PB; Quinn MA; Kirk JA; Stewart CJ; Obermair A; Young JP; Webb PM; Spurdle AB
J Clin Oncol; 2014 Jan; 32(2):90-100. PubMed ID: 24323032
[TBL] [Abstract][Full Text] [Related]
17. Heterogenous loss of mismatch repair (MMR) protein expression: a challenge for immunohistochemical interpretation and microsatellite instability (MSI) evaluation.
McCarthy AJ; Capo-Chichi JM; Spence T; Grenier S; Stockley T; Kamel-Reid S; Serra S; Sabatini P; Chetty R
J Pathol Clin Res; 2019 Apr; 5(2):115-129. PubMed ID: 30387329
[TBL] [Abstract][Full Text] [Related]
18. MSH6 and MUTYH deficiency is a frequent event in early-onset colorectal cancer.
Giráldez MD; Balaguer F; Bujanda L; Cuatrecasas M; Muñoz J; Alonso-Espinaco V; Larzabal M; Petit A; Gonzalo V; Ocaña T; Moreira L; Enríquez-Navascués JM; Boland CR; Goel A; Castells A; Castellví-Bel S
Clin Cancer Res; 2010 Nov; 16(22):5402-13. PubMed ID: 20924129
[TBL] [Abstract][Full Text] [Related]
19. [Expression and clinical significance of MMR protein and MLH1 promoter methylation testing in endometrial cancer].
Jin W; Wang LQ; Liu Y; Liu AJ
Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):823-830. PubMed ID: 30585020
[No Abstract] [Full Text] [Related]
20. Screening for germline mutations of MLH1, MSH2, MSH6 and PMS2 genes in Slovenian colorectal cancer patients: implications for a population specific detection strategy of Lynch syndrome.
Berginc G; Bracko M; Ravnik-Glavac M; Glavac D
Fam Cancer; 2009; 8(4):421-9. PubMed ID: 19526325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
